ALEXZA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEXZA, and when can generic versions of ALEXZA drugs launch?
ALEXZA has one approved drug.
There are five US patents protecting ALEXZA drugs.
There are two hundred and twenty patent family members on ALEXZA drugs in twenty-one countries and ten supplementary protection certificates in eight countries.
Summary for ALEXZA
| International Patents: | 220 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for ALEXZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 9,370,629 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 7,458,374 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 8,991,387 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 8,387,612 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 7,537,009 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALEXZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 7,585,493 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 9,440,034 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 6,716,416 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 8,235,037 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 8,173,107 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 9,439,907 | ⤷ Subscribe |
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | 8,955,512 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALEXZA Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2007516403 | ⤷ Subscribe |
| Denmark | 2052753 | ⤷ Subscribe |
| China | 1662272 | ⤷ Subscribe |
| Germany | 60239604 | ⤷ Subscribe |
| Canada | 2460343 | ⤷ Subscribe |
| China | 101596175 | ⤷ Subscribe |
| Canada | 2526432 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ALEXZA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1389098 | 473 | Finland | ⤷ Subscribe | |
| 1389098 | CA 2013 00046 | Denmark | ⤷ Subscribe | PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220 |
| 1389098 | SPC/GB13/055 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: LOXAPINE; REGISTERED: UK EU/1/13/823/001 20130220; UK EU/1/13/823/002 20130220 |
| 1389098 | 1390040-2 | Sweden | ⤷ Subscribe | PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220 |
| 1389098 | C300609 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
| 1389098 | CR 2013 00046 | Denmark | ⤷ Subscribe | PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220 |
| 1389098 | 300609 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
